The same in other media
27.04 - 19:31
Opinion | Can covid-19 be Indian pharma’s Y2K moment?
Reading now: 762
The country’s pharmaceutical industry has a rare but brief opportunity to capture the global market as the chief supplier of affordable and high-quality hydroxychloroquine Prime Minister Narendra Modi’s medical diplomacy in clearing hydroxychloroquine supplies from India to countries like the US, Brazil and Israel, has won the country brownie points in the midst of the global pandemic.
It also points to a once in a generation opportunity for Indian drug manufacturers as also the wider healthcare sector to become the dominant global supplier of key products and services.
Already, companies like Ipca Laboratories and Zydus Cadilla that produce the “wonder drug", have impressed with their ability to address the sudden demand, with many of
Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|
